Valacyclovir for Herpes Simplex Virus Infection: Long-Term Safety and Sustained Efficacy after 20 Ye...
Valacyclovir for Herpes Simplex Virus Infection: Long-Term Safety and Sustained Efficacy after 20 Years’ Experience with Acyclovir
About this item
Full title
Author / Creator
Publisher
Chicago, IL: The University of Chicago Press
Journal title
Language
English
Formats
Publication information
Publisher
Chicago, IL: The University of Chicago Press
Subjects
More information
Scope and Contents
Contents
An extensive clinical trial program combined with 5 years’ postmarketing experience with valacyclovir provides evidence of favorable safety and efficacy in herpes simplex virus (HSV) management. Valacyclovir enhances acyclovir bioavailability compared with orally administered acyclovir. Long-term use of acyclovir for up to 10 years for HSV suppress...
Alternative Titles
Full title
Valacyclovir for Herpes Simplex Virus Infection: Long-Term Safety and Sustained Efficacy after 20 Years’ Experience with Acyclovir
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_18768479
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_18768479
Other Identifiers
ISSN
0022-1899
E-ISSN
1537-6613
DOI
10.1086/342966
